Free release
9-Bromo-7,12-dihydrobenzo[2,3]azepino[4,5-b]indol-6(5H)-one

9-Bromo-7,12-dihydrobenzo[2,3]azepino[4,5-b]indol-6(5H)-one

CAS No. :142273-20-9MDL No. :MFCD02683595Formula :C16H11BrN2OBoiling Point :-Linear Structure Formula :-InChI Key :QQUXF

Sales:Service@apichina.com
CAS No. :142273-20-9 Brand :Qitai
Formula :C16H11BrN2O M.W :327.18

Introduction

CAS No. :142273-20-9 MDL No. :MFCD02683595
Formula : C16H11BrN2O Boiling Point : -
Linear Structure Formula :- InChI Key :QQUXFYAWXPMDOE-UHFFFAOYSA-N
M.W : 327.18 Pubchem ID :3820
Synonyms :
NSC-664704;9-Bromopaullone;1-azakenpaullone
Chemical Name :9-Bromo-7,12-dihydrobenzo[2,3]azepino[4,5-b]indol-6(5H)-one

Physicochemical Properties

Num. heavy atoms : 20
Num. arom. heavy atoms : 15
Fraction Csp3 : 0.06
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 2.0
Molar Refractivity : 86.73
TPSA : 44.89 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -5.99 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.22
Log Po/w (XLOGP3) : 3.25
Log Po/w (WLOGP) : 3.52
Log Po/w (MLOGP) : 2.99
Log Po/w (SILICOS-IT) : 4.36
Consensus Log Po/w : 3.27

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -4.47
Solubility : 0.0111 mg/ml ; 0.0000338 mol/l
Class : Moderately soluble
Log S (Ali) : -3.87
Solubility : 0.0445 mg/ml ; 0.000136 mol/l
Class : Soluble
Log S (SILICOS-IT) : -7.12
Solubility : 0.0000249 mg/ml ; 0.000000076 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 2.71
Signal Word:Warning Class:N/A
Precautionary Statements:P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319 Packing Group:N/A
GHS Pictogram: